TABLE 1.
Correlation between the clinicopathologic characteristics and CFL1 expression in hepatocellular carcinoma
CFL1 expression | |||||
---|---|---|---|---|---|
Characteristics | n = 100 | Low (n = 50) | High (n = 50) | p | |
Age (year) | <50 | 34 | 15 | 19 | 0.398 |
≥50 | 66 | 35 | 31 | ||
Gender | Male | 84 | 40 | 44 | 0.275 |
Female | 16 | 10 | 6 | ||
HBV infection | Absent | 22 | 16 | 6 | 0.016* |
Present | 78 | 34 | 44 | ||
Serum AFP level (ng/ml) |
<20 | 34 | 20 | 14 | 0.205 |
≥20 | 66 | 30 | 36 | ||
Tumour size (cm) | <5 | 38 | 25 | 13 | 0.013* |
≥5 | 62 | 25 | 37 | ||
Tumour number | 1 | 77 | 43 | 34 | 0.033* |
≥2 | 23 | 7 | 16 | ||
Cirrhosis | Absent | 30 | 19 | 11 | 0.081 |
Present | 70 | 31 | 39 | ||
Venous infiltration | Absent | 58 | 38 | 20 | <0.001* |
Present | 42 | 12 | 30 | ||
Edmondson‐Steiner grading | I+II | 63 | 34 | 29 | 0.300 |
III+IV | 37 | 16 | 21 | ||
TNM stage | I+II | 82 | 47 | 35 | 0.002* |
III+IV | 18 | 3 | 15 |
Abbreviations: AFP, alpha‐fetoprotein; HBV, hepatitis B virus; TNM, tumour‐node‐metastasis.
Indicates statistically significant.